EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Propofol vs. Chlorpromazine for Acute Migraine Treatment: Insights from a Prospective Randomized Trial

Sarper Sağlam, Özlem Güneysel

Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi · 2024

DOI: 10.61745/jsmsau.1584825 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi, 2024. Verfasst von Sarper Sağlam und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to compare the efficacy of propofol and chlorpromazine in managing acute migraine attacks and to contribute to optimizing the treatment of patients with migraine in the ED.

Methods

This prospective, randomized observational study included 180 migraine patients aged 18–65 presenting to the ED. Patients were randomized into two groups: one received propofol (10 mg every 10 minutes, up to 50 mg), and the other received chlorpromazine (12.5 mg every 20 minutes, up to 37.5 mg). Pain was monitored every 10 minutes using a visual analog scale (VAS).

Results

At admission, the mean VAS score was 8.24 ± 1.72 in the propofol group and 8.83 ± 1.43 in the chlorpromazine group. In the propofol group, the VAS score decreased by 5.19 ± 2.79, 2.66 ± 2.91, and 1.25 ± 2.14 units at the 10th, 20th, and 30th minutes, respectively. In the chlorpromazine group, the VAS score decreased by 4.82 ± 2.99, 2.50 ± 2.93, and 1.03 ± 2.20 units at the 10th, 20th, and 30th minutes, respectively. By the 60th minute, the total VAS reduction was 25.00 ± 12.25 in the propofol group and 23.10 ± 11.40 in the chlorpromazine group. Although pain reduction initially occurred more rapidly in the chlorpromazine group, there was no statistically significant difference between the groups at the 60-minute mark.

Conclusion

Propofol was as effective as chlorpromazine for treating migraines in the ED, with a comparable onset of action and a better side-effect profile.

Zitieren

APA

Sağlam, S., & Güneysel, Ö. (2024). Propofol vs. Chlorpromazine for Acute Migraine Treatment: Insights from a Prospective Randomized Trial. Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi. https://doi.org/10.61745/jsmsau.1584825

Vancouver

Sağlam S, Güneysel Ö. Propofol vs. Chlorpromazine for Acute Migraine Treatment: Insights from a Prospective Randomized Trial. Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi. 2024. doi:10.61745/jsmsau.1584825

BibTeX
@article{Salam2024,
  author = {Sağlam, Sarper and Güneysel, Özlem},
  title = {Propofol vs. Chlorpromazine for Acute Migraine Treatment: Insights from a Prospective Randomized Trial},
  journal = {Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi},
  year = {2024},
  doi = {10.61745/jsmsau.1584825}
}
Kostenlos starten →